Technical Analysis for SYN - Synthetic Biologics, Inc.

Grade Last Price % Change Price Change
grade D 0.531 -1.12% -0.01
SYN closed down 1.12 percent on Wednesday, September 18, 2019, on 1.14 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical SYN trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Inside Day Range Contraction -1.12%
Wide Bands Range Expansion -1.12%
Overbought Stochastic Strength -1.12%
Upper Bollinger Band Walk Strength -1.61%
Wide Bands Range Expansion -1.61%
Overbought Stochastic Strength -1.61%
Upper Bollinger Band Touch Strength -1.61%

Older signals for SYN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Synthetics Biologics, Inc., a biotechnology company, focuses on the development of biologics for the prevention and treatment of serious infectious diseases. The company's product candidates include Trimesta, which is in Phase II clinical trial for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis; SYN-004, which is in Phase II clinical trial for the treatment of clostridium difficile infection prevention; SYN-005, which is in preclinical stage for the treatment of pertussis; and SYN-001, which is in discovery stage for the treatment of acinetobacter infection. It has an agreement with Meda AB for the development and commercialization of Effirma (flupirtine) for fibromyalgia in the United States, Canada, and Japan, as well as with The University of Texas at Austin, Intrexon Corporation, and the Regents of the University of California. The company was formerly known as Adeona Pharmaceuticals, Inc. and changed its name to Synthetics Biologics, Inc. in February 2012. Synthetics Biologics, Inc. was founded in 2001 and is based in Rockville, Maryland.
Biotechnology Chemical Compounds Infectious Diseases Multiple Sclerosis Pyridines Carbamates Clostridioides Difficile Clostridium Difficile Infection Fibromyalgia Relapsing Remitting Multiple Sclerosis University Of California Cognitive Dysfunction Flupirtine Microorganisms
Is SYN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.0
52 Week Low 0.365
Average Volume 91,151
200-Day Moving Average 0.5836
50-Day Moving Average 0.4768
20-Day Moving Average 0.4648
10-Day Moving Average 0.5041
Average True Range 0.0365
ADX 24.2
+DI 23.4452
-DI 13.969
Chandelier Exit (Long, 3 ATRs ) 0.4405
Chandelier Exit (Short, 3 ATRs ) 0.4745
Upper Bollinger Band 0.5633
Lower Bollinger Band 0.3663
Percent B (%b) 0.84
BandWidth 42.383821
MACD Line 0.0211
MACD Signal Line 0.0095
MACD Histogram 0.0116
Fundamentals Value
Market Cap 68.1 Million
Num Shares 128 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -3.24
Price-to-Sales 0.00
Price-to-Book 21.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.59
Resistance 3 (R3) 0.59 0.56 0.58
Resistance 2 (R2) 0.56 0.55 0.56 0.58
Resistance 1 (R1) 0.55 0.54 0.56 0.55 0.57
Pivot Point 0.52 0.52 0.53 0.53 0.52
Support 1 (S1) 0.51 0.51 0.52 0.51 0.49
Support 2 (S2) 0.49 0.50 0.49 0.49
Support 3 (S3) 0.47 0.49 0.48
Support 4 (S4) 0.47